本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

7.56
+0.02000.27%
盘前:7.580.0200+0.26%09:13 EDT
成交量:367.04万
成交额:2,787.07万
市值:16.55亿
市盈率:-5.35
高:7.75
开:7.60
低:7.36
收:7.54
52周最高:16.44
52周最低:6.23
股本:2.19亿
流通股本:1.85亿
量比:1.03
换手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
净资产收益率:-72.99%
总资产收益率:-34.95%
市净率:3.18
市盈率(LYR):-5.32

数据加载中...

2024/02/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report
2023/12/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/14

重要事件披露

Form 8-K - Current report